Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ:ABOS
Want to see ABOS full AI Analyst Report?
Acumen Pharmaceuticals (ABOS) Ownership Overview
32.76% Insiders
6.55% Mutual Funds
45.98% Other Institutional Investors
2.42% ETFs
12.29% Public Companies and
Individual Investors
The ownership structure of Acumen Pharmaceuticals (ABOS) stock is a mix of institutional, retail, and individual investors. Approximately 54.96% of the company’s stock is owned by Institutional Investors, 32.76% is owned by Insiders, and 12.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 17, 2026 | xxxxxxxxxxxxx | $75065 | |
Jun 10, 2026 | xxxxxxxxxxxxx | $14272 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $49542699 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,040,969 | Insider | 29.13% | 47,552,590 | |
| 20,992,669 | Institution | 29.06% | 47,443,432 | |
| 1,493,463 | Institution | 2.07% | 3,375,226 | |
| 1,474,477 | Institution | 2.04% | 3,332,318 | |
| 1,140,000 | Institution | 1.58% | 2,576,400 | |
| 881,275 | Insider | 1.22% | 1,991,681 | |
| 826,400 | Institution | 1.14% | 1,867,664 | |
| 700,000 | Institution | 0.97% | 1,582,000 | |
| 345,331 | Institution | 0.48% | 780,448 | |
| 304,924 | Insider | 0.42% | 689,128 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,474,477 | Institution | 2.04% | 3,332,318 | |
| 1,140,000 | Institution | 1.58% | 2,576,400 | |
| 826,400 | Institution | 1.14% | 1,867,664 | |
| 700,000 | Institution | 0.97% | 1,582,000 | |
| 345,331 | Institution | 0.48% | 780,448 | |
| 162,871 | Institution | 0.23% | 368,088 | |
| 39,288 | Institution | 0.05% | 88,791 | |
| 26,300 | Institution | 0.04% | 59,438 | |
| 7,819 | Institution | 0.01% | 17,671 | |
| 5,500 | Institution | <0.01% | 12,430 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,118,322 | Institution | 1.55% | 2,907,637 | |
| 375,141 | Institution | 0.52% | 975,367 | |
| 100,013 | Institution | 0.14% | 225,029 | |
| 97,119 | Institution | 0.13% | 219,489 | |
| 24,136 | Institution | 0.03% | 54,306 | |
| 10,755 | Institution | 0.01% | 25,382 | |
| 9,637 | Institution | 0.01% | 21,683 | |
| 7,149 | Institution | <0.01% | 16,157 | |
| 4,079 | Institution | <0.01% | 9,219 | |
| 3,387 | Institution | <0.01% | 7,655 |
FAQ
Who Owns Acumen Pharmaceuticals, Inc. (ABOS)?
According to the latest TipRanks data, approximately 45.98% of the company's stock is held by institutional investors, 32.76% is held by insiders, and 12.29% is held by retail investors.
What percentage of Acumen Pharmaceuticals, Inc. (ABOS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 45.98% of Acumen Pharmaceuticals, Inc. (ABOS) stock is held by institutional investors.
What percentage of Acumen Pharmaceuticals, Inc. (ABOS) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.29% of Acumen Pharmaceuticals, Inc. (ABOS) stock is held by retail investors.
Who owns the most shares of Acumen Pharmaceuticals, Inc. (ABOS)?
Ra Capital Management, Llc owns the most shares of Acumen Pharmaceuticals, Inc. (ABOS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.